Delivery Order SPE2DB20D9127-SPE2DB22FD3YZ

Award Date 6/7/22
Potential Completion Date 6/29/22
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order type, a ceiling value of $3,124.68, and an ultimate completion date of April 29, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical...
The federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract valued at $7,104.00, with a period of performance through May 20, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger...
The federal contract award is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, with a ceiling value of $2,083.12, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,041.56 and an ultimate completion date of March 11, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $1,726.89 and is a firm fixed-price delivery order with no set-aside designation. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of a larger indefinite delivery contract (IDC) held by DMS...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $59,200.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. specializes in providing a wide range of pharmaceutical...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $5,074.50 and an ultimate completion date of September 27, 2021. The contract is not associated with any set-aside...
This federal contract award is for the delivery of Mirena 52 mg systems, a contraceptive implant, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,184 and a period of performance through July 3, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
This federal contract award is for the delivery of Mirena 52 mg Systems, a type of intrauterine device, to the Defense Logistics Agency (DLA). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order type, with a ceiling value of $4,736.00 and an ultimate completion date of December 26, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency, by the prime contractor DMS Pharmaceutical Group Inc. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $11,840.00 and a period of performance ending on February 22, 2024. It was awarded on January 31, 2024 and does not have a...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB22FD3YZ
    Delivery Order

This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $28,176.50 and has an ultimate completion date of June 29, 2022. This award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 2/27/25, 1:31 PM